GO:0018105 peptidyl-serine phosphorylation: Signaling Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0018105 peptidyl-serine phosphorylation is the biological process of adding a phosphate group to a serine residue within a protein, forming peptidyl-O-phospho-L-serine.
• This modification is catalyzed by serine/threonine kinases and reversed by serine/threonine phosphatases, acting as a central switch in eukaryotic signal transduction.
• Dysregulated serine phosphorylation is implicated in rheumatoid arthritis, cancer progression, and neuropsychiatric disorders.
• Key kinases such as MAST3 and eEF2K are emerging as therapeutic targets and prognostic biomarkers in inflammatory and malignant diseases.
• Advanced mass spectrometry-based enrichment methods now enable global mapping of serine phosphorylation events in complex tissues like mouse brain.
• CRISPR-based knockout, knock-in, and point-mutation models are essential to establish causal roles of specific serine phosphorylation sites in disease.
Description
Peptidyl-serine phosphorylation (GO:0018105) is a fundamental post-translational modification in which a phosphate group is covalently attached to the hydroxyl oxygen of a serine residue within a protein, yielding peptidyl-O-phospho-L-serine. This process is a core component of cellular signaling and is governed by the opposing activities of protein kinases and phosphatases. It is one of the most abundant phosphorylation events in eukaryotes and serves as a molecular switch that modulates protein activity, localization, and interactions. Researchers study peptidyl-serine phosphorylation because it controls virtually every aspect of cell physiology, from proliferation and differentiation to apoptosis and immune responses. Its dysregulation is a hallmark of many human diseases, including autoimmune disorders such as rheumatoid arthritis and various cancers. For example, MAST3, a serine/threonine kinase, modulates inflammatory responses and proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Similarly, eEF2K, which phosphorylates serine residues on elongation factor 2, is associated with cancer survival and prognosis. Understanding the precise sites and dynamics of serine phosphorylation requires advanced technologies. Recent methodological advances, such as efficient enrichment of N-phosphorylation peptides from mouse brain tissue, have expanded our ability to profile this modification in vivo. Moreover, network pharmacology and molecular docking studies have linked serine phosphorylation pathways to the mechanisms of anticancer agents like Huachansu injection and Morusin. This article provides a comprehensive overview of GO:0018105, covering its definition, mechanisms, key genes, disease relevance, and cutting-edge research methods.
peptidyl-serine phosphorylation At A Glance
| GO ID | GO:0018105 |
|---|---|
| GO term | peptidyl-serine phosphorylation |
| Ontology | biological_process |
| Synonym | (none) |
| Major function | Covalent addition of phosphate to serine residues in proteins, a key post-translational modification in signal transduction |
| Catalytic enzymes | Protein serine/threonine kinases (e.g., MAST3, eEF2K) |
| Reversing enzymes | Protein serine/threonine phosphatases |
| Subcellular location | Cytoplasm, nucleus, and other cellular compartments |
| Representative diseases | Rheumatoid arthritis, cancer, depression |
What Is GO:0018105?
According to the Gene Ontology, peptidyl-serine phosphorylation (GO:0018105) is defined as the phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine. In simpler terms, it is the enzymatic addition of a phosphate group to a serine amino acid that is already part of a protein chain. This reaction is catalyzed by protein serine/threonine kinases, which transfer the gamma-phosphate of ATP to the serine hydroxyl group. The reverse reaction is mediated by protein phosphatases. This modification can alter the protein's conformation, activity, subcellular localization, and ability to interact with other molecules, thereby transmitting signals within cells.
Why Is peptidyl-serine phosphorylation Important in Cell Biology?
Peptidyl-serine phosphorylation is a central regulatory mechanism in eukaryotic cells, controlling processes such as cell cycle progression, apoptosis, metabolism, and immune signaling. Its reversible nature allows cells to rapidly respond to internal and external cues. Dysregulation of this process contributes to a wide range of pathologies, including autoimmune diseases, cancer, and neuropsychiatric disorders. Therefore, understanding the enzymes and sites involved is critical for developing targeted therapies and diagnostic biomarkers.
• Regulates protein function, stability, and interactions in virtually all cellular pathways.
• Key role in inflammatory signaling; MAST3 kinase modulates fibroblast-like synoviocyte proliferation in rheumatoid arthritis.
• Influences cancer cell survival and prognosis through kinases such as eEF2K.
• Implicated in the mechanism of action of anticancer agents like Huachansu injection and Morusin.
• Associated with neuropsychiatric conditions such as depression, as suggested by molecular mechanism studies.
• Target of environmental toxicants, e.g., organophosphate pesticides may accelerate biological aging via phosphorylation-related pathways.
• Essential for brain function; methods for enriching N-phosphorylation peptides in mouse brain enable mapping of serine phosphorylation events.
• Provides potential biomarkers for cancer prognosis and treatment response.
• Enables development of kinase inhibitors as therapeutic strategies.
• Forms the basis for CRISPR-based functional studies of specific phosphorylation sites.
What Happens During peptidyl-serine phosphorylation?
Recognition and Binding of Substrate by Kinase
In simple terms: A kinase enzyme finds and grabs onto its target protein.
The process begins when a protein serine/threonine kinase recognizes a specific consensus sequence or structural motif surrounding a serine residue in the substrate protein. This recognition is often mediated by docking interactions, adaptor proteins, or phosphorylation-dependent binding. For example, MAST3 kinase is known to modulate inflammatory responses by phosphorylating specific substrates in fibroblast-like synoviocytes. The binding step ensures specificity and is tightly regulated by cellular signals.
Phosphoryl Transfer from ATP to Serine
In simple terms: The kinase transfers a phosphate group from ATP onto the serine.
Once bound, the kinase catalyzes the transfer of the gamma-phosphate group from ATP to the hydroxyl oxygen of the serine residue. This forms a covalent bond, creating peptidyl-O-phospho-L-serine. This reaction is energetically favorable and requires magnesium ions as cofactors. The catalytic mechanism involves conserved residues in the kinase domain that position the ATP and serine for efficient transfer. This step is the defining event of GO:0018105.
Conformational Change and Functional Consequences
In simple terms: Adding the phosphate changes the protein's shape and behavior.
The addition of a phosphate group introduces a bulky, negatively charged moiety that can induce conformational changes in the target protein. This can activate or inhibit enzymatic activity, create or disrupt binding sites for partner proteins, or alter subcellular localization. For instance, phosphorylation of eEF2K substrates affects protein synthesis and is linked to cancer cell survival. Such functional consequences are central to signal transduction.
Dephosphorylation by Phosphatases
In simple terms: Another enzyme removes the phosphate to reverse the effect.
The phosphorylation mark is reversible. Protein serine/threonine phosphatases catalyze the removal of the phosphate group, restoring the serine hydroxyl. This dynamic equilibrium between kinases and phosphatases allows for tight temporal and spatial control of signaling. Dysregulation of this balance can lead to disease, as seen in rheumatoid arthritis where MAST3 activity is altered.
Integration into Cellular Signaling Networks
In simple terms: This modification is part of a larger communication network inside cells.
Peptidyl-serine phosphorylation is not an isolated event; it is integrated into complex signaling cascades. For example, network pharmacology studies have shown that compounds like Huachansu injection and Morusin affect multiple kinases and phosphorylation pathways in cancer cells. Similarly, environmental factors such as organophosphate pesticides may perturb phosphorylation networks, accelerating biological aging. Thus, this process serves as a hub for cellular decision-making.
Key Genes Involved in GO:0018105 peptidyl-serine phosphorylation
The following genes encode kinases, phosphatases, and substrates that are directly involved in or regulated by peptidyl-serine phosphorylation, with relevance to human disease and research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAST3 | Serine/threonine kinase that modulates inflammatory responses | Implicated in rheumatoid arthritis; regulates fibroblast-like synoviocyte proliferation |
| EEF2K | Phosphorylates elongation factor 2 at serine residues | Associated with cancer survival and prognosis; potential therapeutic target |
| AKT1 | Serine/threonine kinase in PI3K/AKT pathway | Central to cell survival, proliferation; often dysregulated in cancer |
| MAPK1 | Serine/threonine kinase in MAPK cascade | Controls cell growth and differentiation; target in cancer research |
| MTOR | Serine/threonine kinase that regulates translation and metabolism | Key regulator of cell growth; implicated in cancer and aging |
| CDK1 | Cyclin-dependent kinase that phosphorylates serine residues | Drives cell cycle progression; target in oncology |
| GSK3B | Serine/threonine kinase involved in glycogen metabolism and signaling | Linked to neurodegeneration and mood disorders |
| PRKACA | Catalytic subunit of protein kinase A | Mediates cAMP signaling; involved in endocrine diseases |
| CAMK2A | Calcium/calmodulin-dependent kinase | Critical for synaptic plasticity and memory |
| RPS6KB1 | Ribosomal protein S6 kinase | Regulates protein synthesis; role in cancer and metabolic disorders |
| PPP1CA | Protein phosphatase 1 catalytic subunit | Reverses serine phosphorylation; involved in multiple signaling pathways |
| PPP2CA | Protein phosphatase 2 catalytic subunit | Tumor suppressor; dephosphorylates serine/threonine residues |
| SRC | Non-receptor tyrosine kinase that also phosphorylates serine | Oncogene; involved in cancer progression |
| JAK2 | Janus kinase that phosphorylates serine residues on STAT proteins | Implicated in myeloproliferative neoplasms |
| STAT3 | Transcription factor phosphorylated on serine by kinases | Constitutively active in many cancers |
| TP53 | Tumor suppressor phosphorylated on serine residues | Regulates DNA damage response and apoptosis |
| RB1 | Retinoblastoma protein phosphorylated on serine | Cell cycle checkpoint control; mutated in cancers |
| CREB1 | Transcription factor activated by serine phosphorylation | Role in memory, depression, and cancer |
How Is peptidyl-serine phosphorylation Regulated?
Peptidyl-serine phosphorylation is regulated at multiple levels. Kinase activity is controlled by upstream signals such as growth factors, hormones, and stress, often through phosphorylation cascades. For example, the PI3K/AKT/mTOR pathway regulates many serine/threonine kinases, including eEF2K, which in turn affects protein synthesis and cancer cell survival. Phosphatases provide opposing regulation, and their activity is also tightly controlled. Additionally, scaffold proteins and subcellular localization determine substrate specificity. Environmental factors, such as organophosphate pesticides, can disrupt these regulatory networks, potentially accelerating biological aging. In disease states like rheumatoid arthritis, MAST3 kinase activity is modulated by inflammatory cytokines, contributing to synoviocyte proliferation.
peptidyl-serine phosphorylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MAST3 | Rheumatoid arthritis | Knockout or point-mutation in fibroblast-like synoviocytes |
| EEF2K | Cancer survival and prognosis | Knockout in cancer cell lines; xenograft models |
| CREB1 | Depression and neuropsychiatric disorders | Knock-in of phospho-mimetic or phospho-deficient mutants in neurons |
| TP53 | Cancer (DNA damage response) | Point mutation at serine phosphorylation sites in cancer cells |
| AKT1 | Cancer and metabolic disorders | Overexpression or knockout in cell lines and mouse models |
Rheumatoid Arthritis and Inflammatory Diseases
Dysregulated peptidyl-serine phosphorylation plays a key role in rheumatoid arthritis. MAST3, a serine/threonine kinase, modulates the inflammatory response and proliferation of fibroblast-like synoviocytes, which are central to joint destruction in this disease. Targeting MAST3 or its phosphorylation substrates may offer new therapeutic avenues for inflammatory arthritis.
Cancer Progression and Prognosis
Serine phosphorylation is frequently altered in cancer. eEF2K, which phosphorylates elongation factor 2, is associated with cancer survival and prognosis across multiple tumor types. Network pharmacology studies have shown that anticancer agents such as Huachansu injection and Morusin exert their effects by modulating phosphorylation networks, including serine phosphorylation of key signaling proteins. These findings highlight the potential of serine phosphorylation as a biomarker and therapeutic target.
Neuropsychiatric and Aging-Related Disorders
Emerging evidence links serine phosphorylation to neuropsychiatric disorders and aging. Molecular mechanism studies suggest that interactions between heavy metals and depression may involve altered phosphorylation signaling. Additionally, organophosphate pesticide exposure has been associated with accelerated biological aging, potentially through disruption of phosphorylation-dependent pathways. These observations underscore the broad impact of serine phosphorylation on human health.
From peptidyl-serine phosphorylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MAST3 kinase reduce inflammatory synoviocyte proliferation? | MAST3 knockout in rheumatoid arthritis fibroblast-like synoviocytes |
| Does eEF2K phosphorylation status affect cancer cell survival? | EEF2K knockout or point-mutation (kinase-dead) in cancer cell lines |
| What is the role of a specific serine phosphorylation site on TP53? | Knock-in of phospho-deficient (Ser->Ala) or phospho-mimetic (Ser->Asp) TP53 in cancer cells |
| How does CREB1 serine phosphorylation influence depression-like behavior? | Knock-in of phospho-mutant CREB1 in mouse neurons |
| Can overexpression of a constitutively active kinase drive tumorigenesis? | Overexpression of AKT1 or MAST3 in cell lines and xenografts |
| What are the global targets of a serine kinase? | Knockout of the kinase followed by phosphoproteomics |
How to Study the peptidyl-serine phosphorylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics (LC-MS/MS) | Global identification and quantification of serine phosphorylation sites | Mapping signaling networks in tissues and cells |
| In vitro kinase assay | Enzymatic activity of serine/threonine kinases | Screening inhibitors; determining substrate specificity |
| Western blot with phospho-specific antibodies | Levels of specific phosphorylated serine residues | Validating phosphorylation changes in cells and tissues |
| CRISPR knockout | Loss-of-function effects on phosphorylation and phenotype | Establishing causal roles of kinases |
| CRISPR knock-in (point mutation) | Effect of phospho-mimetic or phospho-deficient mutations | Dissecting site-specific functions |
| Network pharmacology | Predicted interactions between compounds and phosphorylation pathways | Drug mechanism studies |
| Molecular docking | Binding affinity of compounds to kinases | Virtual screening for inhibitors |
| Immunoprecipitation | Protein-protein interactions involving phosphorylated proteins | Identifying signaling complexes |
Phosphoproteomics and Mass Spectrometry
Mass spectrometry-based phosphoproteomics is the primary method for identifying and quantifying serine phosphorylation sites. Recent advances include efficient enrichment of N-phosphorylation peptides from mouse brain tissue, which enables comprehensive mapping of phosphorylation events in complex biological samples. These methods can reveal changes in phosphorylation patterns in response to stimuli or disease states.
Kinase Activity Assays
In vitro kinase assays using recombinant kinases and substrate peptides can measure the specific activity of serine/threonine kinases. These assays are useful for screening inhibitors and determining kinetic parameters. For example, MAST3 kinase activity can be assessed using synthetic substrates derived from its target proteins.
CRISPR-Based Functional Studies
CRISPR/Cas9 genome editing allows for the creation of knockout, knock-in, and point-mutation models to study the causal role of specific genes and phosphorylation sites. For instance, knocking out MAST3 in synoviocytes can reveal its contribution to inflammatory responses, while introducing phospho-mutant alleles of eEF2K can dissect its role in cancer.
Network Pharmacology and Bioinformatics
Computational approaches such as network pharmacology and molecular docking are increasingly used to predict kinase-substrate relationships and identify compounds that modulate serine phosphorylation. Studies on Huachansu injection and Morusin have employed these methods to uncover mechanisms of action involving phosphorylation pathways.
How CRISPR Can Be Used to Study GO:0018105 peptidyl-serine phosphorylation
Knockout
CRISPR knockout of genes encoding serine/threonine kinases or phosphatases is a powerful approach to study their role in peptidyl-serine phosphorylation. For example, knocking out MAST3 in fibroblast-like synoviocytes can determine its contribution to inflammatory responses in rheumatoid arthritis. Similarly, EEF2K knockout in cancer cells can reveal its impact on survival and prognosis. Knockout models are essential for establishing causality.
Point Mutation
Introducing point mutations at specific serine residues (e.g., Ser to Ala to prevent phosphorylation, or Ser to Asp to mimic phosphorylation) allows researchers to dissect the function of individual phosphorylation sites. This is particularly useful for studying transcription factors like TP53 or CREB1, where site-specific phosphorylation dictates downstream effects. CRISPR-mediated point mutations provide precise genetic control.
Knock-in
Knock-in of tagged or reporter alleles can be used to track the localization and dynamics of phosphorylated proteins in live cells. For instance, knocking in a fluorescent tag at the endogenous locus of a kinase can reveal its spatiotemporal activation. This approach is valuable for understanding how serine phosphorylation is regulated in real time.
Overexpression
Overexpression of wild-type or constitutively active kinases using CRISPR activation or lentiviral delivery can drive excessive serine phosphorylation and model disease states. For example, overexpressing MAST3 or AKT1 can mimic the hyperphosphorylation seen in cancer and inflammatory diseases. Overexpression models are useful for gain-of-function studies and drug screening.
How EDITGENE Supports peptidyl-serine phosphorylation Research
Researchers studying peptidyl-serine phosphorylation-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. Establishing causality requires precise genetic manipulation, such as knocking out the gene, introducing disease-associated point mutations, or creating knock-in reporters. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for peptidyl-serine phosphorylation research.
Frequently Asked Questions About peptidyl-serine phosphorylation
What is peptidyl-serine phosphorylation?
Peptidyl-serine phosphorylation (GO:0018105) is the addition of a phosphate group to a serine residue in a protein, forming peptidyl-O-phospho-L-serine. It is a key post-translational modification in cell signaling.
What genes are involved in peptidyl-serine phosphorylation?
Genes encoding serine/threonine kinases such as MAST3, EEF2K, AKT1, and MAPK1, as well as phosphatases like PPP1CA, are involved. These enzymes add or remove phosphate groups on serine residues.
How is peptidyl-serine phosphorylation regulated?
It is regulated by the opposing activities of kinases and phosphatases, upstream signaling pathways (e.g., PI3K/AKT/mTOR), and scaffold proteins. Environmental factors can also disrupt this balance.
What diseases are associated with abnormal peptidyl-serine phosphorylation?
Dysregulation is linked to rheumatoid arthritis, cancer, depression, and aging-related disorders. For example, MAST3 is implicated in rheumatoid arthritis, and eEF2K in cancer prognosis.
What methods are used to study peptidyl-serine phosphorylation?
Common methods include phosphoproteomics, in vitro kinase assays, Western blotting with phospho-specific antibodies, and CRISPR-based genetic models.
How can CRISPR be used to study peptidyl-serine phosphorylation?
CRISPR enables knockout, knock-in, and point mutation of genes encoding kinases, phosphatases, or substrate proteins, allowing causal studies of specific phosphorylation events.
What is the role of MAST3 in rheumatoid arthritis?
MAST3 is a serine/threonine kinase that modulates inflammatory responses and proliferation of fibroblast-like synoviocytes, contributing to rheumatoid arthritis pathogenesis.
How does eEF2K affect cancer?
eEF2K phosphorylates elongation factor 2 and is associated with cancer survival and prognosis, making it a potential therapeutic target.
Can peptidyl-serine phosphorylation be targeted therapeutically?
Yes, kinase inhibitors targeting serine/threonine kinases are under development for cancer and inflammatory diseases. For example, compounds like Morusin modulate phosphorylation pathways.
What is the difference between serine and tyrosine phosphorylation?
Serine phosphorylation occurs on serine residues and is mediated by serine/threonine kinases, while tyrosine phosphorylation occurs on tyrosine residues and is mediated by tyrosine kinases. Both are key signaling modifications but involve different enzymes and targets.
Conclusion
Peptidyl-serine phosphorylation (GO:0018105) is a cornerstone of cellular signaling, regulating diverse processes from inflammation to cancer progression. Its reversible nature and widespread occurrence make it a critical node for therapeutic intervention. Advances in phosphoproteomics and CRISPR genome editing are accelerating our understanding of this modification in health and disease. As research continues to uncover the specific kinases, phosphatases, and substrates involved, new opportunities for targeted therapies will emerge. EDITGENE's comprehensive CRISPR services and bioinformatics support empower researchers to dissect the causal roles of serine phosphorylation in their disease models, ultimately driving the development of novel treatments.
References
- 1. Xu Q et al.. 2019. MAST3 modulates the inflammatory response and proliferation of fibroblast-like synoviocytes in rheumatoid arthritis.. Int Immunopharmacol 77:105900 PMID: 31644963
- 2. Cheng Z et al.. 2025. Integrating epidemiological and bioinformatics analyses identified the effects of organophosphate pesticides accelerating biological aging.. Int J Surg 112(4):9587-604 PMID: 41427534
- 3. Pan H et al.. 2023. Efficient Enrichment Method for N-Phosphorylation Peptides in Mouse Brain Tissue.. J Am Soc Mass Spectrom 34(2):145-148 PMID: 36637179
- 4. Liu M et al.. 2025. Exploring the Mechanism of Huachansu Injection for Lung Cancer Based on Network Pharmacology and Molecular Docking.. Curr Pharm Des PMID: 41277136
- 5. Nguyen HD et al.. 2023. Interactions between cadmium, lead, mercury, and arsenic and depression: A molecular mechanism involved.. J Affect Disord 327:315-329 PMID: 36758875
- 6. Wang N et al.. 2024. eEF2K as an important kinase associated with cancer survival and prognosis.. Sci Rep 14(1):29284 PMID: 39592671
- 7. Yang M et al.. 2026. Integrated analysis of Morusin inhibiting esophageal cancer via network pharmacology molecular dynamics simulation and in vitro validation.. Discov Oncol 17(1) PMID: 41870738
